NCT07319624

Brief Summary

This prospective study evaluates the feasibility and safety of using Electrical Impedance Tomography (EIT) to guide PEEP selection in mechanically ventilated infants and toddlers under 3 years of age. This population is challenging for its variety and anatomophysiologic peculiarity. A decremental PEEP trial using 1 cmH₂O steps following a recruitment maneuver at 35 cmH₂O was compared between EIT and other best PEEP assessment protocols.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

November 23, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 6, 2026

Completed
Last Updated

January 6, 2026

Status Verified

December 1, 2025

Enrollment Period

5 months

First QC Date

November 23, 2025

Last Update Submit

December 20, 2025

Conditions

Keywords

EITPEEPMechanical VentilationElectrical Impedence TomographyPARDS

Outcome Measures

Primary Outcomes (1)

  • Feasibility (% of patients that complete the EIT-guided PEEP trial)

    assessing the feasibility of an individualized PEEP titration using an EIT-guided decremental PEEP trial specifically designed for smaller children.

    20 weeks

Secondary Outcomes (5)

  • To compare PEEPeit (cmH2O) with PEEPnih (cmH2O)

    20 weeks

  • To evaluate changes of EIT patterns of overdistension (%) and derecruitment (%) according to changes in respiratory system Compliance-guided method (mL/cmH2O)

    20 weeks

  • To assess changes in respiratory system compliance (mL/cmH2O) across different PEEP levels (cmH2O)

    20 weeks

  • To assess changes in end-expiratory lung impedance (arbitrary units) by EIT across different PEEP levels (cmH2O)

    20 weeks

  • To assess changes in oxygenation (PaO2/FiO2, mmHg) across different PEEP levels

    20 weeks

Study Arms (1)

Pediatric Acute Respiratory Distress Syndrome (PARDS) patients

EXPERIMENTAL

Patients under 3 years of age who required mechanical ventilation due to impaired oxygenation or altered respiratory mechanics.

Diagnostic Test: Electrical Impedence Tomography

Interventions

An EIT belt with 16 electrodes (PulmoVista® 500, Dräger Medical GmbH, Lübeck, Germany) appropriate to the children's weight was placed at the fourth or fifth intercostal space along the axillary line.

Pediatric Acute Respiratory Distress Syndrome (PARDS) patients

Eligibility Criteria

Age0 Years - 3 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age under 3
  • Impaired oxygenation - defined as an
  • oxygenation Index (OI = mean airway pressure multiplied by FiO₂ divided by PaO₂) greater than 4; and/or
  • an Oxygen Saturation Index (OSI = mean airway pressure multiplied by FiO₂ divided by SpO₂) greater than 5; or
  • altered respiratory mechanics - defined as reduced respiratory system compliance normalized to body weight (Crs/kg) below 0.7 mL/cmH₂O/kg.

You may not qualify if:

  • thoracic fractures
  • chest drains
  • subcutaneous thoracic devices
  • presence of intracardiac shunts
  • confirmed or suspected pneumothorax on chest X-ray or lung ultrasound
  • hemodynamic instability requiring adrenaline or noradrenaline at doses exceeding 0.05 mcg/kg/min, or a reduction in systolic blood pressure greater than 30% during recruitment maneuvers.
  • technical issues that prevented reliable acquisition of EIT signals, including prolonged signal instability
  • belt-to-chest size incompatibility (\< 3 kg)
  • lack of informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Papa Giovanni XXIII Hospital, Bergamo, BG 24100

Bergamo, Italy, 24100, Italy

Location

MeSH Terms

Conditions

Pneumonia

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Alfio Bronco, MD

    Papa Giovanni XXIII Hospital, Bergamo, BG 24100

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator - Consultant Pediatric Intensivist

Study Record Dates

First Submitted

November 23, 2025

First Posted

January 6, 2026

Study Start

December 1, 2024

Primary Completion

April 30, 2025

Study Completion

April 30, 2025

Last Updated

January 6, 2026

Record last verified: 2025-12

Locations